These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maternal serum screening of Palestinian women in the West Bank. Husseini A; Akkawi M East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399 [TBL] [Abstract][Full Text] [Related]
3. [Triple test: problem or enhancement of prenatal diagnosis]. Rauskolb R; Engel W Z Geburtshilfe Neonatol; 1995; 199(3):91. PubMed ID: 7553260 [No Abstract] [Full Text] [Related]
4. [Maternal serum screening for detection of fetal chromosome abnormalities]. Holzgreve W; Miny P; Schloo R; Tercanli S Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824 [No Abstract] [Full Text] [Related]
6. Prenatal biochemical screening for Down's syndrome and neural tube defects. Wald NJ; Kennard A Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963 [TBL] [Abstract][Full Text] [Related]
7. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors. Kloza EM Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365 [No Abstract] [Full Text] [Related]
8. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18. Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study]. Aymé S; Aurran Y; Chabal F; Gombert A; Loundou H; Montfort C; Sollier M; Silvestri A Contracept Fertil Sex; 1993 Feb; 21(2):133-43. PubMed ID: 7524931 [TBL] [Abstract][Full Text] [Related]
11. Down syndrome: prenatal risk assessment and diagnosis. Newberger DS Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860 [TBL] [Abstract][Full Text] [Related]
12. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test]. van den Boer-van den Berg JM; Dupuis HM Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445 [No Abstract] [Full Text] [Related]
14. Test pest. Hammond P Nurs Times; 1994 Aug 10-16; 90(32):60. PubMed ID: 7521958 [No Abstract] [Full Text] [Related]
15. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis. Mennuti M JAMA; 1996 May; 275(18):1440-6. PubMed ID: 8618372 [No Abstract] [Full Text] [Related]
16. [Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening]. Wildhagen MF; Christiaens GC; Habbema JD Ned Tijdschr Geneeskd; 1996 Jan; 140(2):85-9. PubMed ID: 8569927 [TBL] [Abstract][Full Text] [Related]
17. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography. Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168 [TBL] [Abstract][Full Text] [Related]
18. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach]. Senat MV; Rozenberg P; Bernard JP; Ville Y J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502 [No Abstract] [Full Text] [Related]
19. Prenatal detection of Down syndrome. Smith CV Nebr Med J; 1995 Aug; 80(8):268-70. PubMed ID: 7566251 [No Abstract] [Full Text] [Related]
20. Biochemical screening tests for Down syndrome. Coetzee E; Viljoen D S Afr Med J; 1995 Feb; 85(2):72-3. PubMed ID: 7541163 [No Abstract] [Full Text] [Related] [Next] [New Search]